Weekly Research Analysts’ Ratings Changes for Avantor (AVTR)

A number of firms have modified their ratings and price targets on shares of Avantor (NYSE: AVTR) recently:

• 7/29/2024 – Avantor had its price target raised by analysts at Morgan Stanley from $28.00 to $29.00. They now have an “overweight” rating on the stock.
• 7/29/2024 – Avantor had its price target raised by analysts at Barclays PLC from $25.00 to $28.00. They now have an “overweight” rating on the stock.
• 7/29/2024 – Avantor had its “outperform” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $31.00 price target on the stock.
• 7/29/2024 – Avantor had its price target raised by analysts at Robert W. Baird from $26.00 to $27.00. They now have an “outperform” rating on the stock.
• 7/29/2024 – Avantor had its price target raised by analysts at TD Cowen from $28.00 to $31.00. They now have a “buy” rating on the stock.
• 7/29/2024 – Avantor had its price target raised by analysts at Stifel Nicolaus from $27.00 to $28.00. They now have a “buy” rating on the stock.
• 7/15/2024 – Avantor had its price target raised by analysts at Royal Bank of Canada from $30.00 to $31.00. They now have an “outperform” rating on the stock.
• 7/10/2024 – Avantor was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating. They now have a $23.00 price target on the stock, down previously from $30.00.
• 7/2/2024 – Avantor had its price target lowered by analysts at Evercore ISI from $28.00 to $27.00. They now have an “outperform” rating on the stock.
• 6/28/2024 – Avantor had its price target lowered by analysts at Barclays PLC from $28.00 to $25.00. They now have an “overweight” rating on the stock.

Avantor Stock Performance

AVTR traded down $1.10 on Friday, reaching $25.40. 2,100,001 shares of the stock were exchanged, compared to its average volume of 7,040,287. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05. The company’s 50-day moving average price is $22.56 and its 200 day moving average price is $23.76. The firm has a market capitalization of $17.27 billion, a PE ratio of 65.13, a PEG ratio of 2.73 and a beta of 1.32. Avantor, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $28.00.

Insider Transactions at Avantor

In related news, insider Christophe Couturier 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On Avantor

A number of institutional investors have recently modified their holdings of AVTR. Versant Capital Management Inc grew its holdings in Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after acquiring an additional 1,102 shares during the period. Fifth Third Bancorp increased its holdings in shares of Avantor by 125.3% during the 4th quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after purchasing an additional 694 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of Avantor by 565.5% in the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock valued at $30,000 after purchasing an additional 1,131 shares during the period. Blue Trust Inc. boosted its holdings in Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after buying an additional 1,391 shares in the last quarter. Finally, Gladius Capital Management LP acquired a new stake in Avantor during the fourth quarter valued at $42,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.